Recurrent Breast Cancer Completed Phase 2 Trials for Trastuzumab (DB00072)

Also known as: Breast Cancer Recurrent / Breast cancer NOS recurrent / Carcinoma breast recurrent / Breast carcinoma recurrent / Breast carcinoma NOS recurrent

IndicationStatusPhase
DBCOND0028640 (Recurrent Breast Cancer)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00004888Combination Chemotherapy With or Without Trastuzumab in Treating Women With Metastatic Breast CancerTreatment
NCT00006228Trastuzumab and Interleukin-2 in Treating Patients With Metastatic Breast CancerTreatment
NCT00024154Trastuzumab and Gefitinib in Treating Patients With Metastatic Breast CancerTreatment
NCT00077376Trastuzumab, Ixabepilone, and Carboplatin in Treating Patients With HER2/Neu-Positive Metastatic Breast CancerTreatment